&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif; 2026-04-21, 06:00

Essential Pharma 旗下公司 Renaissance Pharma Limited 用于治疗高危神经母细胞瘤的 Daretabart (hu1418K322A) 获得 FDA 快速通道认定，并通过 IND 审评

Notified -

&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif; 2025-02-06, 15:00

Essential Pharma and Clinigen Expand Collaboration to Improve Patient Access in JAPAC
Tony Loman

Notified -

&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif; 2024-12-12, 14:00

Essential Pharma announces €900 million recapitalisation through a Gyrus Capital Continuation Vehicle led by AlpInvest and new strategic financing from Sixth Street

Notified -

&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif; 2024-04-17, 13:00

Essential Pharma Announces the Acquisition of Reminyl® (galantamine hydrobromide) Oral Capsules
Kristofer Henninger

&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif; 2024-04-09, 13:00

Essential Pharma acquires Renaissance Pharma Ltd with its clinical stage immunotherapy for the treatment of high-risk neuroblastoma
Etsuko Liu

Notified -

&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif; 2024-01-08, 14:00

Essential Pharma acquires European rights to Colobreathe®(colistimethate sodium) from Teva
Micheal Moe

Popular Posts